Prof. Jihong Liu: National Authority in Gynecologic Oncology, Fertility-Sparing Surgery & Molecular Targeted Care at Sun Yat-sen University Cancer Center

Professional Profile

Prof. Jihong Liu is a nationally acclaimed gynecologic surgical oncologist, Chief Physician, Professor, Doctoral Supervisor, and Director of the Gynecologic Oncology Center at Sun Yat-sen University Cancer Center (SYSUCC). Widely revered as one of China’s leading clinical leaders in female pelvic malignancies, Prof. Liu has dedicated her career to establishing high-precision surgical benchmarks and molecular-driven systemic protocols for gynecological tumors.

At SYSUCC, Prof. Liu heads one of Asia’s largest and most advanced gynecologic oncology referral programs. She is renowned for tackling complex pelvic and peritoneal malignancies, pioneering nerve-sparing pelvic lymphadenectomies, and introducing cutting-edge fertility-preserving surgical interventions that enable young women to achieve cancer cure while safeguarding their reproductive potential.

Key Clinical Specializations

• Cervical Cancer & Nerve-Sparing Radical Surgery: Mastery in radical hysterectomy and pelvic lymph node dissection for cervical carcinoma. Prof. Liu emphasizes autonomic nerve preservation to safeguard bladder, rectal, and sexual function, as well as multidisciplinary combinations with immune checkpoint inhibitors for locally advanced and recurrent cases.
• Maximal Cytoreductive Surgery for Advanced Ovarian Cancer: Expert in ultra-radical primary debulking surgery (PDS) and interval debulking surgery (IDS) to achieve complete macroscopic resection (R0), coupled with hyperthermic intraperitoneal chemotherapy (HIPEC) and systematic upper abdominal cytoreduction.
• Fertility-Sparing Surgical Innovations: Pioneering radical vaginal and abdominal trachelectomy, uterine-sparing resections, and ovarian transposition for early-stage cervical, ovarian, and endometrial cancers, enabling young cancer survivors to achieve healthy subsequent pregnancies.
• Endometrial Cancer & Molecular Subtyping: Incorporating TCGA and ProMisE molecular classifications (POLE, MMRd, p53abn, NSMP) to tailor conservative endocrine preservation versus radical staging lymphadenectomies.

Academic Leadership & Landmark Research (2024–2025)

Prof. Jihong Liu is a prolific translational scientist and principal investigator on leading international clinical trials, with pivotal 2024–2025 contributions featured in premier global medical journals:

• Landmark Publications in Journal of Clinical Oncology (JCO): Unveiling multi-center phase III randomized trial outcomes evaluating PARP inhibitor maintenance regimens tailored by homologous recombination deficiency (HRD) and BRCA status in advanced ovarian cancer, demonstrating unprecedented progression-free survival gains.
• Breakthroughs in Gynecologic Oncology: Leading national multicenter clinical studies on checkpoint inhibitor combinations in recurrent and persistent cervical cancer, establishing novel biomarker-guided therapeutic pathways.
• National Clinical Practice Guidelines: Authoring and chairing Chinese national consensus guidelines on ovarian cancer surgical staging, cervical cancer fertility-preserving surgery, and standardized PARP inhibitor clinical application.

International Patient Coordination & Fast-Track Access

China Medical Concierge – Shanghai (CMCS) provides dedicated health management and medical concierge services connecting domestic and overseas patients with China’s premier oncology leaders. For patients seeking consultation and advanced gynecological surgical planning with Prof. Jihong Liu at SYSUCC, CMCS offers comprehensive support:

• Remote multidisciplinary review of pelvic MRI, contrast-enhanced CT, PET-CT, and pathology biopsy slides;
• Fast-track outpatient appointments and expedited surgical admission coordination at SYSUCC;
• Expert evaluation for fertility preservation eligibility and participation in innovative PARP inhibitor or immunotherapy clinical trials;
• Full-course medical translation, bilingual patient accompaniment, and longitudinal postoperative follow-up care.